Paying users zone. Data is covered by .

  • Get to Amgen Inc. for $17.99, or

  • get to whole website for at least 3 months from $49.99.

 

$17.99

Present Value of Free Cash Flow to Equity (FCFE)

Difficulty: Intermediate

In discounted cash flow (DCF) valuation techniques the value of the stock is estimated based upon present value of some measure of cash flow. Free cash flow to equity (FCFE) is generally described as cash flows available to the equity holder after payments to debt holders and after allowing for expenditures to maintain the company's asset base.


Intrinsic Stock Value (Valuation Summary)

Amgen Inc., free cash flow to equity (FCFE) forecast

USD $ in millions, except per share data

 
Year Value FCFEt or Terminal value (TVt) Calculation Present value at %
01 FCFE0
1 FCFE1 = × (1 + %)
2 FCFE2 = × (1 + %)
3 FCFE3 = × (1 + %)
4 FCFE4 = × (1 + %)
5 FCFE5 = × (1 + %)
5 Terminal value (TV5) = × (1 + %) ÷ (% – %)
Intrinsic value of Amgen's common stock
Intrinsic value of Amgen's common stock (per share) $
Current share price $

Disclaimer!
Valuation is based on standard assumptions. There may exist specific factors relevant to stock value and omitted here. In such a case, the real stock value may differ significantly form the estimated. If you want to use the estimated intrinsic stock value in investment decision making process, do so at your own risk.

Top


Required Rate of Return (r)

 
Assumptions
Rate of return on LT Treasury Composite1 RF %
Expected rate of return on market portfolio2 E(RM) %
Systematic risk (β) of Amgen's common stock βAMGN
Required rate of return on Amgen's common stock3 rAMGN %

1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).

Calculations

2 See Details »

3 rAMGN = RF + βAMGN [E(RM) – RF]
= % + [% – %]
= %

Top


FCFE Growth Rate (g)

FCFE growth rate (g) implied by PRAT model

Amgen Inc., PRAT model

 
Average Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Dividends
Net income
Product sales
Total assets
Stockholders' equity
Ratios
Retention rate1
Profit margin2 % % % % %
Asset turnover3
Financial leverage4
Averages
Retention rate
Profit margin %
Asset turnover
Financial leverage
Growth rate of FCFE (g)5 %

2017 Calculations

1 Retention rate = (Net income – Dividends) ÷ Net income
= () ÷ =

2 Profit margin = 100 × Net income ÷ Product sales
= 100 × ÷ = %

3 Asset turnover = Product sales ÷ Total assets
= ÷ =

4 Financial leverage = Total assets ÷ Stockholders' equity
= ÷ =

5 g = Retention rate × Profit margin × Asset turnover × Financial leverage
= × % × × = %

Top


FCFE growth rate (g) implied by single-stage model

g = 100 × (Equity market value0 × r – FCFE0) ÷ (Equity market value0 + FCFE0)
= 100 × ( × % – ) ÷ ( + ) = %

where:
Equity market value0 = current market value of Amgen's common stock (USD $ in millions)
FCFE0 = last year Amgen's free cash flow to equity (USD $ in millions)
r = required rate of return on Amgen's common stock

Top


FCFE growth rate (g) forecast

Amgen Inc., H-model

 
Year Value gt
1 g1 %
2 g2 %
3 g3 %
4 g4 %
5 and thereafter g5 %

where:
g1 is implied by PRAT model
g5 is implied by single-stage model
g2, g3 and g4 are calculated using linear interpoltion between g1 and g5

Calculations

g2 = g1 + (g5g1) × (2 – 1) ÷ (5 – 1)
= % + (% – %) × (2 – 1) ÷ (5 – 1) = %

g3 = g1 + (g5g1) × (3 – 1) ÷ (5 – 1)
= % + (% – %) × (3 – 1) ÷ (5 – 1) = %

g4 = g1 + (g5g1) × (4 – 1) ÷ (5 – 1)
= % + (% – %) × (4 – 1) ÷ (5 – 1) = %

Top